NCT00291772View on ClinicalTrials.gov

Continuous Subcutaneous Infusion of Pramlintide and Insulin

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Type 1 Diabetes
Interventions
DRUG

Pramlintide

Basal and bolus pramlintide subcutaneous infusion

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT00291772 - Continuous Subcutaneous Infusion of Pramlintide and Insulin | Biotech Hunter | Biotech Hunter